Insider Transactions Reported by 15 Insiders of Better Therapeutics, Inc.

Location
San Francisco, CA

There are no Buy or Sell transactions made by insiders since 09 Jan 2025

Better Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
DAVID P. PERRY Executive Chairman, Director, 10%+ Owner $3,695,296 09 Feb 2024
Georgianna Maule-Ffinch 2015 Trust 10%+ Owner $617,818 10 Apr 2023
Kevin J. Appelbaum Chief Executive Officer, Director, 10%+ Owner $409,964 31 Mar 2022
Geoffrey Parker Director $184,365 18 Dec 2023
Andrew Armanino Director $126,653 18 Dec 2023
FRANK KARBE Chief Executive Officer, Director $89,455 18 Dec 2023
Mark A. Berman Chief Medical Officer $76,139 18 Dec 2023
Kristin Wynholds Chief Product Officer $38,335 18 Dec 2023
Richard H. Carmona Director $26,737 18 Dec 2023
Mark Heinen Chief Financial Officer $24,126 01 Mar 2023
Elder Granger Director $6,728 18 Dec 2023
Justin Zamirowski Chief Commercial Officer $6,272 27 May 2022
Leslie Miller Principal Accounting Officer $3,047 18 Dec 2023
RISA J. LAVIZZO-MOUREY Director $2,336 18 Dec 2023
Suying Liu Director 09 Jun 2022

Recent Insider Transactions by Companies or Individuals for Better Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.